List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 726 studies with search of: cancer | wake forest
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Aspirin in Reducing Events in the Elderly
Conditions: Functional Disability;   Dementia;   Heart Disease;   Stroke;   Cancer;   Bleeding
Interventions: Drug: 100 mg enteric-coated aspirin;   Drug: Placebo
2 Recruiting Soy Protein/Isoflavones and Venlafaxine in Treating Hot Flashes in Patients Receiving Hormone Therapy for Prostate Cancer
Conditions: Hot Flashes;   Prostate Cancer
Interventions: Dietary Supplement: soy isoflavones;   Dietary Supplement: soy protein isolate;   Drug: venlafaxine;   Other: placebo
3 Active, not recruiting A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers
Conditions: Chronic Myelogenous Leukemia;   Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive);   Hypereosinophilic Syndrome;   Systemic Mastocytosis
Intervention: Drug: AMN107
4 Recruiting Study to Evaluate Exemestane With and Without SNDX-275 in Treatment of Postmenopausal Women With Advanced Breast Cancer
Conditions: Breast Cancer;   Estrogen Receptor-Positive Breast Cancer;   Breast Cancer, Estrogen Receptor-Positive;   ER+ Breast Cancer
Interventions: Drug: SNDX-275;   Drug: exemestane
5 Active, not recruiting OVATURE (OVArian TUmor REsponse) Study: A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
Conditions: Fallopian Tube Cancer;   Peritoneal Neoplasms;   Ovarian Cancer
Interventions: Drug: phenoxodiol;   Drug: carboplatin
6 Completed Genetic Analysis of Hereditary Prostate Cancer
Conditions: Hereditary Neoplastic Syndrome;   Prostatic Neoplasm
Intervention:
7 Not yet recruiting Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Biological: panitumumab;   Drug: paclitaxel;   Drug: carboplatin;   Procedure: laboratory biomarker analysis;   Procedure: immunohistochemistry staining method
8 Recruiting A Phase I/Expansion Study of Dasatinib
Conditions: Refractory Solid Tumors;   Pancreatic Adenocarcinoma
Interventions: Drug: gemcitabine;   Drug: dasatinib
9 Active, not recruiting Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Biological: bevacizumab;   Drug: carboplatin;   Drug: paclitaxel;   Other: placebo
10 Active, not recruiting Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Biological: filgrastim;   Biological: pegfilgrastim;   Drug: docetaxel;   Drug: trabectedin
11 Active, not recruiting Screening Study of Surgery and CA 125 Levels in Participants at Increased Genetic Risk of Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Other: cancer prevention;   Other: physiologic testing;   Other: screening questionnaire administration;   Procedure: annual screening;   Procedure: comparison of screening methods;   Procedure: conventional surgery;   Procedure: evaluation of cancer risk factors;   Procedure: long-term screening;   Procedure: study of high risk factors
12 Recruiting Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Drug: paclitaxel;   Drug: paclitaxel poliglumex;   Other: clinical observation
13 Recruiting Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Biological: bevacizumab;   Drug: carboplatin;   Drug: docetaxel;   Drug: paclitaxel
14 Active, not recruiting Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer
Conditions: Breast Cancer;   Fatigue;   Ovarian Cancer;   Psychosocial Effects of Cancer and Its Treatment
Interventions: Other: questionnaire administration;   Procedure: fatigue assessment and management;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment;   Procedure: stress management therapy;   Procedure: yoga therapy
15 Recruiting Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
Conditions: Breast Cancer;   Metastatic Cancer;   Multiple Myeloma and Plasma Cell Neoplasm;   Musculoskeletal Complications;   Pain;   Prostate Cancer;   Urinary Complications
Intervention: Drug: zoledronic acid
16 Recruiting Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer
Condition: Kidney Cancer
Interventions: Genetic: gene expression analysis;   Genetic: protein expression analysis;   Other: laboratory biomarker analysis
17 Active, not recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Intervention: Drug: paclitaxel albumin-stabilized nanoparticle formulation
18 Recruiting Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants
Conditions: Bladder Cancer;   Kidney Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter;   Urethral Cancer
Interventions: Other: immunologic technique;   Other: laboratory biomarker analysis;   Other: mass spectrometry
19 Active, not recruiting Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Dietary Supplement: selenium;   Other: placebo
20 Active, not recruiting Intraperitoneal Hyperthermic Perfusion With Oxaliplatin in Treating Patients With Stage IV Peritoneal Cancer Due to Appendix Cancer or Colorectal Cancer
Conditions: Carcinoma of the Appendix;   Colorectal Cancer;   Peritoneal Cavity Cancer
Interventions: Drug: oxaliplatin;   Genetic: protein expression analysis;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: conventional surgery;   Procedure: hyperthermia treatment

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services